The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Prothena Corporation plc(NASDAQ:PRTA) 
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing PRX002/RG7935 that is in Phase 2 clinical trial for treating Parkinson's disease and other relate...
Website: http://www.prothena.com
Founded: 2012
Full Time Employees: 51
Sector: Healthcare
Industry: Biotechnology
Prothena plc Days Payable Outstanding ttm (DPO)
Prothena plc Days Receivable Outstanding ttm (DSO)
Prothena plc Days Inventory Outstanding ttm (DIO)
Prothena plc Op Cashflow Per Share ttm
Prothena plc Free Cashflow Per Share ttm
Prothena plc Cash Per Share ttm
Prothena plc P/S ratio ttm
Prothena plc (GAAP) P/E ratio ttm
Prothena plc P/B ratio ttm
No extra charts and metrics for this ticker.